Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Scorpius Holdings, Inc. | Chief Executive Officer, Director | Common Stock | 3.57M | May 16, 2024 | Direct | ||
Scorpius Holdings, Inc. | Chief Executive Officer, Director | Warrant (right to buy) | 2.5M | May 16, 2024 | Direct | ||
Theriva Biologics, Inc. | Director | Stock Options (right to buy) | 110K | Dec 14, 2023 | Direct | ||
Scorpius Holdings, Inc. | Chief Executive Officer, Director | Common Stock | 10.2K | May 16, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SCPX | Scorpius Holdings, Inc. | May 16, 2024 | 2 | $0 | 4 | May 17, 2024 | Chief Executive Officer, Director |
TOVX | Theriva Biologics, Inc. | Dec 14, 2023 | 1 | $0 | 4 | Dec 15, 2023 | Director |
TOVX | Theriva Biologics, Inc. | Dec 15, 2022 | 1 | $0 | 4 | Dec 16, 2022 | Director |
NHWK | NightHawk Biosciences, Inc. | Dec 7, 2022 | 1 | $0 | 4 | Dec 9, 2022 | Chief Executive Officer, Director |
NHWK | HEAT BIOLOGICS, INC. | Dec 30, 2021 | 2 | $0 | 4 | Jan 3, 2022 | Chief Executive Officer, Director |
TOVX | Synthetic Biologics, Inc. | Dec 23, 2021 | 1 | $0 | 4 | Dec 27, 2021 | Director |
NHWK | HEAT BIOLOGICS, INC. | Dec 13, 2021 | 2 | $0 | 4 | Dec 15, 2021 | Chief Executive Officer, Director |